Cargando…
APIM-peptide targeting PCNA improves the efficacy of docetaxel treatment in the TRAMP mouse model of prostate cancer
Docetaxel is the chemotherapeutic choice for metastatic hormone-refractory prostate cancer, however, it only marginally improves the survival rate. The purpose of the present study was to examine if a peptide targeting the cellular scaffold protein PCNA could improve docetaxel’s efficacy. We found t...
Autores principales: | Søgaard, Caroline K., Moestue, Siver A., Rye, Morten B., Kim, Jana, Nepal, Anala, Liabakk, Nina-Beate, Bachke, Siri, Bathen, Tone F., Otterlei, Marit, Hill, Deborah K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5837745/ https://www.ncbi.nlm.nih.gov/pubmed/29545934 http://dx.doi.org/10.18632/oncotarget.24357 |
Ejemplares similares
-
Targeting the non-canonical roles of PCNA modifies and increases the response to targeted anti-cancer therapy
por: Søgaard, Caroline K., et al.
Publicado: (2019) -
APIM-Mediated REV3L–PCNA Interaction Important for Error Free TLS Over UV-Induced DNA Lesions in Human Cells
por: Ræder, Synnøve Brandt, et al.
Publicado: (2018) -
“Two hits - one stone”; increased efficacy of cisplatin-based therapies by targeting PCNA’s role in both DNA repair and cellular signaling
por: Søgaard, Caroline Krogh, et al.
Publicado: (2018) -
Peptides containing the PCNA interacting motif APIM bind to the β-clamp and inhibit bacterial growth and mutagenesis
por: Nedal, Aina, et al.
Publicado: (2020) -
Increased Anticancer Efficacy of Intravesical Mitomycin C Therapy when Combined with a PCNA Targeting Peptide()
por: Gederaas, Odrun A., et al.
Publicado: (2014)